Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

7.94
+0.02000.25%
Post-market: 7.950.0100+0.13%19:04 EDT
Volume:819.45K
Turnover:6.60M
Market Cap:692.03M
PE:-3.73
High:8.23
Open:7.90
Low:7.79
Close:7.92
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.72
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.61
PE(LYR):-4.25

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Olema Pharmaceuticals (OLMA), Damora Therapeutics (DMRA)

TIPRANKS
·
Aug 11

Imunon Q2 Net Loss Widens Slightly as R&D Costs Rise

Reuters
·
Aug 11

Tyler Van Buren Reiterates Buy on Olema, Citing Palazestrant’s Late-Stage Differentiation and Multiple Value-Creating Catalysts

TIPRANKS
·
Aug 11

Olema Pharmaceuticals: Buy Rating Reiterated as Palazestrant Phase 3 Catalysts Loom; $24 Price Target Maintained

TIPRANKS
·
Aug 11

Earnings Flash (OLMA) Olema Pharmaceuticals Posts Q2 Loss per Share $0.61, vs. FactSet Est of $0.55 Loss

MT Newswires Live
·
Aug 11

DiaMedica Q2 Net Loss Widen Less than Expected

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Biotech Firm Nkarta Posts Q2 Net Loss; Cash Runway into 2029

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 EPS $(0.61) Misses $(0.55) Estimate

Benzinga Earnings
·
Aug 11

Palisade Bio Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Olema Net Loss Widens 44.29% to $63.2 Million in Q2 FY26

Reuters
·
Aug 11

Olema Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 Net Loss Widens on Higher Clinical Trial Spending

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 Net Income USD -63.2 Million

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 EPS USD -0.61

THOMSON REUTERS
·
Aug 11

Olema Pharmaceuticals, - Completes Enrollment in Phase 3 Opera-01 Trial; Top-Line Data Expected Q1 2027

THOMSON REUTERS
·
Aug 11

Press Release: Olema Oncology Reports Second Quarter 2026 Financial and Operating Results

Dow Jones
·
Aug 11

U.S. Earnings Preview: After Market Close Aug. 7

Dow Jones
·
Aug 08

Olema Grants Stock Options for 254,540 Shares to Seven New Employees Under Inducement Plan

Reuters
·
Aug 05

Olema Oncology Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 05